Clinical experience with intraoperative floppy-iris syndrome. Results of the 2008 ASCRS member survey.
According to an online survey, most members of the American Society of Cataract and Refractive Surgery believe that tamsulosin makes cataract surgery more difficult (95%) and increases the risks of surgery (77%). Commonly reported complications of intraoperative floppy-iris syndrome (IFIS) were significant iris trauma and posterior capsule rupture, with 52% and 23% of respondents, respectively, reporting these complications at a higher rate than in non-IFIS eyes. There was no single preferred surgical method for managing IFIS; 33% of respondents routinely used multiple strategies. Of respondents with sufficient experience, 90% believe that IFIS is more likely with tamsulosin than with nonspecific alpha1-antagonists. Ninety-one percent believe that physicians prescribing alpha1-antagonists should become better educated about IFIS, and 59% would recommend a pretreatment ophthalmic evaluation for patients with cataracts or decreased vision. If they themselves had mildly symptomatic cataracts, 64% of respondents would avoid taking tamsulosin or would have their cataract removed first.
dceye@earthlink.net
David F
DF
Chang
Rosa
R
Braga-Mele
Nick
N
Mamalis
Samuel
S
Masket
Kevin M
KM
Miller
Louis D
LD
Nichamin
Richard B
RB
Packard
Mark
M
Packer
D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects*; D002387:Cataract Extraction; D006306:Health Surveys; D006801:Humans; D007431:Intraoperative Complications / Q000517:prevention & control*; D007499:Iris Diseases / Q000139:chemically induced / Q000517:prevention & control*; D008297:Male; D009885:Ophthalmology / Q000706:statistics & numerical data*; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011470:Prostatic Hyperplasia / Q000188:drug therapy; D012955:Societies, Medical / Q000706:statistics & numerical data; D011795:Surveys and Questionnaires; D013577:Syndrome; D014481:United States
D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists